相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation
Niloofar Hemati et al.
RESULTS IN CHEMISTRY (2022)
Toward stimulating apoptosis in human lung adenocarcinoma cells by novel nano-carmofur compound treatment
Emre Comlekci et al.
ANTI-CANCER DRUGS (2021)
N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production
Parmanand Malvi et al.
MOLECULAR METABOLISM (2021)
The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease
Adam J. Guenzel et al.
GENETICS IN MEDICINE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Zhenming Jin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Repurposing Low-Molecular-Weight Drugs against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2
Jia Gao et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
Repurposing anticancer drugs for the management of COVID-19
Khalid El Bairi et al.
EUROPEAN JOURNAL OF CANCER (2020)
Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer
Rachael E. Clifford et al.
CELLS (2020)
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
撤稿声明: HCFU inhibits cervical cancer cells growth and metastasis by inactivating Wnt/β-catenin pathway (Retraction of 2017)
Ping Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
Maria L. Beltran-Quintero et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Cross-Linked Reverse Vesicle as a General and Effective Vehicle for Hydrophobic Drugs
Jing Zhang et al.
LANGMUIR (2019)
A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities
Kangni Wu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target
Yedda Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Electrospun oral formulations for combined photo-chemotherapy of colon cancer
Heyu Li et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur
Alexey Dementiev et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Pharmacological inhibition of pigmentation in Cryptococcus
Ana Claudia G. Zimbres et al.
FEMS YEAST RESEARCH (2019)
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK - mediated signalling
Marko Klobucar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma
Andrew M. Donson et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges
Ha S. Nguyen et al.
PHARMACEUTICS (2018)
Electrosprayed Janus Particles for Combined Photo-Chemotherapy
Brenda Sanchez-Vazquez et al.
AAPS PHARMSCITECH (2017)
Acid ceramidase confers radioresistance to glioblastoma cells
Ninh B. Doan et al.
ONCOLOGY REPORTS (2017)
Light-driven liquid metal nanotransformers for biomedical theranostics
Svetlana A. Chechetka et al.
NATURE COMMUNICATIONS (2017)
Acid ceramidase is a novel drug target for pediatric brain tumors
Ninh B. Doan et al.
ONCOTARGET (2017)
Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency
Ninh B. Doan et al.
ONCOTARGET (2017)
Acid Ceramidase in Melanoma EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION
Natalia Realini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms
Nelson S. Torres et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs
Jadd Shelton et al.
CHEMICAL REVIEWS (2016)
Atom based 3D-QSAR studies on 2,4-dioxopyrimidine-1-carboxamide analogs: Validation of experimental inhibitory potencies towards acid ceramidase
Debojit Bhattacherjee et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Benzoxazolone Carboxamides: Potent and Systemically Active Inhibitors of Intracellular Acid Ceramidase
Daniela Pizzirani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and in vitro antiproliferative effect
Ilona Domracheva et al.
TOXICOLOGY REPORTS (2015)
Discovery of a New Class of Highly Potent Inhibitors of Acid Ceramidase: Synthesis and Structure-Activity Relationship (SAR)
Daniela Pizzirani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Natalia Realini et al.
SCIENTIFIC REPORTS (2013)
Anti-Tumor Activity of Carmofur Water-Solubilized by Lactic Acid Oligomer-Grafted Pullulan Nanogels
Nobuhiko Miyazaki et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2009)
Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients
J. M. Baehring et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Efficacy of oral anticancer agents for colorectal cancer
Junichi Sakamoto et al.
DISEASES OF THE COLON & RECTUM (2006)
Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil
Masahiko Watanabe et al.
LANGENBECKS ARCHIVES OF SURGERY (2006)
Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels
S Soni et al.
JOURNAL OF DRUG TARGETING (2006)
Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials
JOURNAL OF CLINICAL ONCOLOGY (2004)
Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (Mixed compound of tegafur and uracil), carmofur and 5′-deoxy-5-fluorouridine
K Ooi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer
P Osterlund et al.
ONCOLOGY (2001)
Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy
A Fujikawa et al.
EUROPEAN RADIOLOGY (2001)